Evaluating the Association Between Medical Nutrition Therapy and Morbidity Indicators Among End-Stage Renal Disease Patients on Maintenance Hemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202601690105971

Enrollment

Registered

2026-01-27

Start date

2024-01-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Kidney Disease

Interventions

Control no intervention

Medical nutrition therpay

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ESKD patients receiving hemodialysis

Exclusion criteria

Exclusion criteria: Autoimmune diseases Active malignancy Pregnancy Incremental dialysis

Design outcomes

Primary

Measure	Time frame
1. Changes in nutrition status as assessed by SGA and GLIM Criteria. 2- Comorbidity burden as measured by Charleston Comorbidity index	—

Secondary

Measure	Time frame
Improvement in a- anthropometric measurements as weight and BMI, b- Laboratory parameters as renal function tests, serum phosphorus, serum potassium, uric acid, and hemoglobin levels	—

Countries

Egypt

Contacts

Public ContactYaser Sallam

Clinical Dietitain at Al SaudiGerman Hospital

Yasersalam2020@gmail.com+201007104907

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026